Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20190218006
TCTR20190218006
Recruiting
Phase 4

Oral indomethacin for the prevention of post-ERCP pancreatitis: A Randomized Controlled Trial

The Gastroenterological Association of Thailand0 sites350 target enrollmentFebruary 18, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionspost&#45ERCP complications (including bleeding&#44biliary infection&#44perforation and any adverse outcomes requiring hospital admission or prolonged hospital stay for further management) were monitored. PatPost&#45ERCP pancreatitis

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
post&#45
Sponsor
The Gastroenterological Association of Thailand
Enrollment
350
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 18, 2019
End Date
February 17, 2020
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patient (aged 18\-85 years) with naïve papilla planned for diagnostic or therapeutic ERCP were eligible for enrollment in the study

Exclusion Criteria

  • •contraindication to ERCP, allergy to NSAIDs, contraindication to NSAIDs (including gastrointestinal hemorrhage within 4 weeks or renal dysfunction with serum creatinine \> 1\.4 mg/dl), previous biliary sphincterotomy, active pancreatitis, previous post\-ERCP pancreatitis, active cardiovascular or cerebrovascular disease, unwilling or inability to provide consent and pregnant or breastfeeding women.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
Rectal Indomethacin to Prevent Post ESWL-pancreatitisPancreatitis
NCT02797067Changhai Hospital1,370
Recruiting
Not Applicable
Comparison of two doses of Dexmedetomidine for preventing delirium in wome
CTRI/2023/05/053201niversity College of Medical Siences
Recruiting
Phase 3
Treatment with Oral Diazepam for Prevention of Recurrence of Seizures following DTP and MMR Vaccinatio
IRCT20210619051624N1Ahvaz University of Medical Sciences30
Completed
Phase 2
Rectal Indomethacin in the Prevention of Post-ERCP PancreatitisPost-ERCP Pancreatitis
NCT01912716Indiana University1,037
Recruiting
Phase 2
Role of indomethacin suppository as a possible means to reduce complications related to Pancreatoduodenectomy.Health Condition 1: K860- Alcohol-induced chronic pancreatitisHealth Condition 2: K862- Cyst of pancreasHealth Condition 3: C241- Malignant neoplasm of ampulla of VaterHealth Condition 4: C240- Malignant neoplasm of extrahepaticbile ductHealth Condition 5: C250- Malignant neoplasm of head of pancreasHealth Condition 6: K831- Obstruction of bile ductHealth Condition 7: K861- Other chronic pancreatitisHealth Condition 8: K838- Other specified diseases of biliary tract
CTRI/2020/09/028027Institute of Liver and Biliary Sciences